{
    "xml": "<topic id=\"PHP7653\" outputclass=\"drug\" rev=\"1.18\" type=\"drug\" namespace=\"/drugs/diflucortolone-valerate\" basename=\"diflucortolone-valerate\" title=\"DIFLUCORTOLONE VALERATE\">\n<title>DIFLUCORTOLONE VALERATE</title>\n<body>\n<data name=\"vtmid\">116581007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_832374428\" title=\"Corticosteroids\">Corticosteroids</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34550\" title=\"CORTICOSTEROIDS (TOPICAL)\" namespace=\"/drug-classes/corticosteroids-topical\">CORTICOSTEROIDS (TOPICAL)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP41657\" outputclass=\"indicationsAndDose\" rev=\"1.28\" parent=\"/drugs/diflucortolone-valerate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids (using 0.3% diflucortolone valerate)</p>\n<p outputclass=\"therapeuticIndication\">Short-term treatment of severe exacerbations (using 0.3% diflucortolone valerate)</p>\n<p outputclass=\"therapeuticIndication\">Psoriasis (using 0.3% diflucortolone valerate)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the skin</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 4&#8211;17 years</p>\n<p>Apply 1&#8211;2 times a day for up to 2 weeks, reducing strength as condition responds, to be applied thinly; maximum 60&#8239;g per week.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply 1&#8211;2 times a day for up to 2 weeks, reducing strength as condition responds, to be applied thinly; maximum 60&#8239;g per week.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids (using 0.1% diflucortolone valerate)</p>\n<p outputclass=\"therapeuticIndication\">Psoriasis (using 0.1% diflucortolone valerate)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the skin</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>Apply 1&#8211;2 times a day for up to 4 weeks, to be applied thinly.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply 1&#8211;2 times a day for up to 4 weeks, to be applied thinly.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"potency\">\n<title>Potency</title>\n<p>Diflucortolone valerate 0.1% cream and ointment: potent.</p>\n<p>Diflucortolone valerate 0.3% cream and ointment: very potent.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41434\" outputclass=\"unlicensedUse\" rev=\"1.9\" parent=\"/drugs/diflucortolone-valerate\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">topical</ph> use in children</p>\n<p>\n<i>Nerisone</i>\n<sup>\n<tm tmtype=\"reg\"/>\n</sup> licensed for use in children (age range not specified by manufacturer); <i>Nerisone Forte</i>\n<sup>\n<tm tmtype=\"reg\"/>\n</sup> not licensed for use in children under 4 years.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP61531\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.10\" parent=\"/drugs/diflucortolone-valerate\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Patients or carers should be advised on application of diflucortolone valerate containing preparations.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP7653-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/diflucortolone-valerate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76346\" title=\"Cream\" namespace=\"/drugs/diflucortolone-valerate/cream\">Cream</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76354\" title=\"Ointment\" namespace=\"/drugs/diflucortolone-valerate/ointment\">Ointment</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34550\" namespace=\"/drug-classes/corticosteroids-topical\" title=\"CORTICOSTEROIDS (TOPICAL)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (TOPICAL)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76346\" namespace=\"/drugs/diflucortolone-valerate/cream\" title=\"Cream\" count=\"1\" rel=\"link\">Cream</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76354\" namespace=\"/drugs/diflucortolone-valerate/ointment\" title=\"Ointment\" count=\"1\" rel=\"link\">Ointment</xref>\n</links>\n</topic>",
    "id": "PHP7653",
    "outputclass": "drug",
    "rev": "1.18",
    "type": "drug",
    "namespace": "/drugs/diflucortolone-valerate",
    "basename": "diflucortolone-valerate",
    "title": "DIFLUCORTOLONE VALERATE",
    "vtmid": "116581007",
    "drugClassification": [
        "Corticosteroids"
    ],
    "inheritsFromClass": [
        "CORTICOSTEROIDS (TOPICAL)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids (using 0.3% diflucortolone valerate)",
                        "html": "Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids (using 0.3% diflucortolone valerate)"
                    },
                    {
                        "textContent": "Short-term treatment of severe exacerbations (using 0.3% diflucortolone valerate)",
                        "html": "Short-term treatment of severe exacerbations (using 0.3% diflucortolone valerate)"
                    },
                    {
                        "textContent": "Psoriasis (using 0.3% diflucortolone valerate)",
                        "html": "Psoriasis (using 0.3% diflucortolone valerate)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the skin"
                    ],
                    "textContent": "To the skin",
                    "html": "To the skin"
                },
                "child": [
                    {
                        "textContent": "Apply 1&#8211;2 times a day for up to 2 weeks, reducing strength as condition responds, to be applied thinly; maximum 60 g per week.",
                        "html": "<p>Apply 1&#8211;2 times a day for up to 2 weeks, reducing strength as condition responds, to be applied thinly; maximum 60&#8239;g per week.</p>",
                        "ageGroup": "4&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Apply 1&#8211;2 times a day for up to 2 weeks, reducing strength as condition responds, to be applied thinly; maximum 60 g per week.",
                        "html": "<p>Apply 1&#8211;2 times a day for up to 2 weeks, reducing strength as condition responds, to be applied thinly; maximum 60&#8239;g per week.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids (using 0.1% diflucortolone valerate)",
                        "html": "Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids (using 0.1% diflucortolone valerate)"
                    },
                    {
                        "textContent": "Psoriasis (using 0.1% diflucortolone valerate)",
                        "html": "Psoriasis (using 0.1% diflucortolone valerate)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the skin"
                    ],
                    "textContent": "To the skin",
                    "html": "To the skin"
                },
                "child": [
                    {
                        "textContent": "Apply 1&#8211;2 times a day for up to 4 weeks, to be applied thinly.",
                        "html": "<p>Apply 1&#8211;2 times a day for up to 4 weeks, to be applied thinly.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Apply 1&#8211;2 times a day for up to 4 weeks, to be applied thinly.",
                        "html": "<p>Apply 1&#8211;2 times a day for up to 4 weeks, to be applied thinly.</p>"
                    }
                ]
            }
        ],
        "potency": [
            {
                "type": "potency",
                "title": "Potency",
                "textContent": "Diflucortolone valerate 0.1% cream and ointment: potent.\n\nDiflucortolone valerate 0.3% cream and ointment: very potent.",
                "html": "<p>Diflucortolone valerate 0.1% cream and ointment: potent.</p><p>Diflucortolone valerate 0.3% cream and ointment: very potent.</p>"
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With topical use in children",
                    "html": "With <ph outputclass=\"route\">topical</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "topical"
                    ]
                },
                "textContent": "Nerisone licensed for use in children (age range not specified by manufacturer); Nerisone Forte not licensed for use in children under 4 years.",
                "html": "<p>\n<i>Nerisone</i>\n<sup>\n<tm tmtype=\"reg\"/>\n</sup> licensed for use in children (age range not specified by manufacturer); <i>Nerisone Forte</i>\n<sup>\n<tm tmtype=\"reg\"/>\n</sup> not licensed for use in children under 4 years.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Patients or carers should be advised on application of diflucortolone valerate containing preparations.",
                "html": "<p>Patients or carers should be advised on application of diflucortolone valerate containing preparations.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76346",
                "label": "Cream",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76354",
                "label": "Ointment",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "drugClass": [
            {
                "id": "PHP34550",
                "label": "CORTICOSTEROIDS (TOPICAL)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76346",
                "label": "Cream",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76354",
                "label": "Ointment",
                "type": "medicinalForm"
            }
        ]
    }
}